These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 16289980

  • 1. Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization.
    Di Franco A, Bacci E, Bartoli ML, Cianchetti S, Dente FL, Taccola M, Vagaggini B, Zingoni M, Paggiaro PL.
    Pulm Pharmacol Ther; 2006; 19(5):353-60. PubMed ID: 16289980
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations.
    Belda J, Margarit G, Martínez C, Bellido-Casado J, Casan P, Torrejón M, Brufal M, Rodríguez-Jerez F, Sanchis J.
    Eur Respir J; 2007 Dec; 30(6):1143-9. PubMed ID: 17690122
    [Abstract] [Full Text] [Related]

  • 3. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.
    in't Veen JC, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH.
    Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385
    [Abstract] [Full Text] [Related]

  • 4. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
    Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM.
    N Engl J Med; 2009 Mar 05; 360(10):985-93. PubMed ID: 19264687
    [Abstract] [Full Text] [Related]

  • 5. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 05; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 6. Eosinophilic bronchitis in asthma: a model for establishing dose-response and relative potency of inhaled corticosteroids.
    Kelly MM, Leigh R, Jayaram L, Goldsmith CH, Parameswaran K, Hargreave FE.
    J Allergy Clin Immunol; 2006 May 05; 117(5):989-94. PubMed ID: 16675323
    [Abstract] [Full Text] [Related]

  • 7. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.
    Vignola AM, Riccobono L, Profita M, Foresi A, Di Giorgi R, Guerrera D, Gjomarkaj M, Di Blasi P, Paggiaro PL.
    Allergy; 2005 Dec 05; 60(12):1511-7. PubMed ID: 16266383
    [Abstract] [Full Text] [Related]

  • 8. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
    Jiang YW, Sun YC, Zhou QT, Gai XY, Cao WL, Yao WZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun 05; 30(6):447-51. PubMed ID: 17673020
    [Abstract] [Full Text] [Related]

  • 9. Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics.
    Kawayama T, Kinoshita T, Imaoka H, Gauvreau GM, O'Byrne PM, Aizawa H.
    Respirology; 2008 Nov 05; 13(7):1000-1007. PubMed ID: 18699801
    [Abstract] [Full Text] [Related]

  • 10. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
    Ohbayashi H.
    Arerugi; 2005 Jan 05; 54(1):24-35. PubMed ID: 15841673
    [Abstract] [Full Text] [Related]

  • 11. Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma.
    Jayaram L, Duong M, Pizzichini MM, Pizzichini E, Kamada D, Efthimiadis A, Hargreave FE.
    Eur Respir J; 2005 Jan 05; 25(1):41-6. PubMed ID: 15640321
    [Abstract] [Full Text] [Related]

  • 12. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED, Linnhof AE, Homik L, Freudensprung U, Smau L, Engelstätter R.
    Pulm Pharmacol Ther; 2008 Jan 05; 21(2):264-75. PubMed ID: 17604664
    [Abstract] [Full Text] [Related]

  • 13. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment.
    Pizzichini MM, Pizzichini E, Clelland L, Efthimiadis A, Mahony J, Dolovich J, Hargreave FE.
    Am J Respir Crit Care Med; 1997 May 05; 155(5):1501-8. PubMed ID: 9154849
    [Abstract] [Full Text] [Related]

  • 14. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma.
    Nocker RE, Out TA, Weller FR, de Riemer MJ, Jansen HM, van der Zee JS.
    J Lab Clin Med; 2000 Jul 05; 136(1):39-49. PubMed ID: 10882226
    [Abstract] [Full Text] [Related]

  • 15. Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma.
    Foresi A, Mastropasqua B, Chetta A, D'Ippolito R, Testi R, Olivieri D, Pelucchi A.
    Chest; 2005 Jan 05; 127(1):117-24. PubMed ID: 15653971
    [Abstract] [Full Text] [Related]

  • 16. The effect of montelukast on eosinophil apoptosis: induced sputum findings of patients with mild persistent asthma.
    Abadoglu O, Mungan D, Aksu O, Erekul S, Misirligil Z.
    Allergol Immunopathol (Madr); 2005 Jan 05; 33(2):105-11. PubMed ID: 15808118
    [Abstract] [Full Text] [Related]

  • 17. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
    Ohbayashi H, Adachi M.
    Allergol Int; 2008 Sep 05; 57(3):231-9. PubMed ID: 18493166
    [Abstract] [Full Text] [Related]

  • 18. Analysis of sputum cell counts during spontaneous moderate exacerbations of asthma in comparison to the stable phase.
    Di Franco A, Bartoli ML, Carnevali S, Cianchetti S, Bacci E, Dente FL, Giannini D, Taccola M, Vagaggini B, Paggiaro PL.
    J Asthma; 2003 Apr 05; 40(2):155-62. PubMed ID: 12765317
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 05; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 20. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.
    Noonan M, Chervinsky P, Busse WW, Weisberg SC, Pinnas J, de Boisblanc BP, Boltansky H, Pearlman D, Repsher L, Kellerman D.
    Am J Respir Crit Care Med; 1995 Nov 05; 152(5 Pt 1):1467-73. PubMed ID: 7582278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.